-1.jpg)
.png)
The life sciences industry is highly susceptible to cyber-attacks, posing significant risks. This industry faces a multitude of cyber threats, including but not limited to intellectual property theft, phishing attacks, ransomware, supply chain vulnerabilities, and IoT vulnerabilities. These challenges necessitate a robust and proactive approach to cybersecurity to protect sensitive research data, proprietary formulas, patient information, and proprietary manufacturing processes.
The combined average cost of a data breach for pharmaceutical and biomedical organizations
(2022 Cost of a Data Breach Report by IBM Security)
average known security vulnerabilities per medical device.
(2022 Private Industry Notification by the FBI’s Cyber Division)
higher than the average cost. The cost of data breaches in both the life sciences and healthcare industries surpasses the average cost across all industries by a staggering 80%
(2022 Healthcare breach costs hit record high Report HealthCare IT News)
of pharmaceutical firms surveyed experienced at least one intrusion in 2021.
(2021 State of Pharmaceuticals and Cybersecurity Report by Fortinet)
We provide customized cybersecurity solutions for pharmaceutical, biotech, medical device, and CRO companies, leveraging our industry expertise to address unique challenges and regulatory needs in life sciences. Our approach encompasses robust defense strategies, real-time threat detection through advanced technologies, vulnerability assessments, and comprehensive compliance assurance, ensuring adherence to HIPAA, GDPR, and FDA guidelines.
By choosing FourCorners Cyber as your cybersecurity partner, life sciences companies can focus on their core mission of advancing healthcare while having peace of mind that their valuable data and operations are safeguarded against evolving cyber threats.
The pharmaceutical sector's digital transformation necessitates robust cybersecurity measures to safeguard valuable intellectual property, research findings, and patients' privacy.
.jpg)
The rapid growth of biotechnology research and the increasing reliance on digital infrastructure emphasizes the need for strong cybersecurity measures to protect critical scientific data, prevent unauthorized access, and safeguard intellectual property.
Cybersecurity is paramount in the medical devices sector, where the integration of digital technologies and connectivity exposes devices to potential security vulnerabilities, necessitating the implementation of our product to safeguard patient safety and protect sensitive health information.
With the increasing reliance on digital platforms and data-driven research, CROs require robust cybersecurity measures to mitigate the risk of data breaches and unauthorized access and protect the confidentiality and integrity of clinical trial data.
.svg)